Improving regulatory T cell production through mechanosensing
- PMID: 38450935
- PMCID: PMC11065567
- DOI: 10.1002/jbm.a.37702
Improving regulatory T cell production through mechanosensing
Abstract
Induced Tregs (iTregs) have great promise in adoptive immunotherapy for treatment of autoimmune diseases. This report investigates the impacts of substrate stiffness on human Treg induction, providing a powerful yet simple approach to improving production of these cells. Conventional CD4+ human T cells were activated on materials of different elastic modulus and cultured under suppressive conditions. Enhanced Treg induction was observed on softer materials as early as 3 days following activation and persisted for multiple weeks. Substrate stiffness also affected epigenetic modification of Treg specific genes and Treg suppressive capacity. Tregs induced on substrates of an optimal stiffness balance quantity and suppressive quality.
Keywords: PDMS; T cells; Treg induction; Treg statbility; Treg suppressive capacity.
© 2024 Wiley Periodicals LLC.
Conflict of interest statement
Conflicts of interest: The authors have declared that no conflict of interest exists.
Figures





References
-
- Li YF, et al. The proportion of peripheral regulatory T cells in patients with Multiple Sclerosis: A meta-analysis. Mult Scler Relat Disord. 2019;28:75–80. - PubMed
-
- Jamshidian A, et al. Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms. J Neuroimmunol. 2013;262(1–2):106–12. - PubMed
-
- Lifshitz GV, et al. Ex vivo expanded regulatory T cells CD4(+)CD25(+)FoxP3(+)CD127(Low) develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis. Autoimmunity. 2016;49(6):388–96. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Research Materials